nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CTSL—meningioma	0.888	1	CbGaD
Boceprevir—CTSV—Endosomal/Vacuolar pathway—CTSL—meningioma	0.00889	0.0937	CbGpPWpGaD
Boceprevir—CTSV—Trafficking and processing of endosomal TLR—CTSL—meningioma	0.00777	0.0819	CbGpPWpGaD
Boceprevir—CTSK—Trafficking and processing of endosomal TLR—CTSL—meningioma	0.00644	0.0679	CbGpPWpGaD
Boceprevir—CTSS—Endosomal/Vacuolar pathway—CTSL—meningioma	0.00606	0.0639	CbGpPWpGaD
Boceprevir—CTSS—Trafficking and processing of endosomal TLR—CTSL—meningioma	0.0053	0.0559	CbGpPWpGaD
Boceprevir—CTSK—skull—meningioma	0.00504	0.302	CbGeAlD
Boceprevir—CTSK—Collagen degradation—CTSL—meningioma	0.00273	0.0288	CbGpPWpGaD
Boceprevir—CTSV—Assembly of collagen fibrils and other multimeric structures—CTSL—meningioma	0.00256	0.027	CbGpPWpGaD
Boceprevir—CTSK—Osteoclast Signaling—PDGFB—meningioma	0.00253	0.0267	CbGpPWpGaD
Boceprevir—CTSV—MHC class II antigen presentation—AP1B1—meningioma	0.00232	0.0245	CbGpPWpGaD
Boceprevir—CTSL—MHC class II antigen presentation—AP1B1—meningioma	0.00232	0.0245	CbGpPWpGaD
Boceprevir—CTSK—MHC class II antigen presentation—AP1B1—meningioma	0.00192	0.0203	CbGpPWpGaD
Boceprevir—CTSV—Antigen processing-Cross presentation—CTSL—meningioma	0.00182	0.0192	CbGpPWpGaD
Boceprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—CTSL—meningioma	0.00175	0.0184	CbGpPWpGaD
Boceprevir—CTSV—Collagen formation—CTSL—meningioma	0.00175	0.0184	CbGpPWpGaD
Boceprevir—CTSV—Degradation of the extracellular matrix—CTSL—meningioma	0.00167	0.0176	CbGpPWpGaD
Boceprevir—CTSS—MHC class II antigen presentation—AP1B1—meningioma	0.00158	0.0167	CbGpPWpGaD
Boceprevir—CMA1—Peptide hormone metabolism—TSHB—meningioma	0.00157	0.0165	CbGpPWpGaD
Boceprevir—CMA1—Degradation of the extracellular matrix—CTSL—meningioma	0.00155	0.0163	CbGpPWpGaD
Boceprevir—CTSV—MHC class II antigen presentation—CTSL—meningioma	0.0015	0.0158	CbGpPWpGaD
Boceprevir—CTSK—Degradation of the extracellular matrix—CTSL—meningioma	0.00138	0.0146	CbGpPWpGaD
Boceprevir—CTSV—medulla oblongata—meningioma	0.00129	0.0774	CbGeAlD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—PLAUR—meningioma	0.00127	0.0134	CbGpPWpGaD
Boceprevir—CTSS—Antigen processing-Cross presentation—CTSL—meningioma	0.00124	0.0131	CbGpPWpGaD
Boceprevir—CTSK—MHC class II antigen presentation—CTSL—meningioma	0.00124	0.0131	CbGpPWpGaD
Boceprevir—CTSS—Collagen formation—CTSL—meningioma	0.00119	0.0126	CbGpPWpGaD
Boceprevir—CTSV—Toll-Like Receptors Cascades—CTSL—meningioma	0.00115	0.0122	CbGpPWpGaD
Boceprevir—CTSV—spinal cord—meningioma	0.00115	0.069	CbGeAlD
Boceprevir—CTSS—Degradation of the extracellular matrix—CTSL—meningioma	0.00114	0.012	CbGpPWpGaD
Boceprevir—CTSL—medulla oblongata—meningioma	0.00106	0.0632	CbGeAlD
Boceprevir—CTSS—MHC class II antigen presentation—CTSL—meningioma	0.00102	0.0108	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—PLAU—meningioma	0.000979	0.0103	CbGpPWpGaD
Boceprevir—CTSK—Toll-Like Receptors Cascades—CTSL—meningioma	0.000957	0.0101	CbGpPWpGaD
Boceprevir—CTSL—spinal cord—meningioma	0.000942	0.0564	CbGeAlD
Boceprevir—CTSK—medulla oblongata—meningioma	0.000796	0.0476	CbGeAlD
Boceprevir—CTSS—Toll-Like Receptors Cascades—CTSL—meningioma	0.000788	0.0083	CbGpPWpGaD
Boceprevir—CTSL—cerebellum—meningioma	0.000747	0.0447	CbGeAlD
Boceprevir—CTSV—brain—meningioma	0.000742	0.0444	CbGeAlD
Boceprevir—CTSV—Class I MHC mediated antigen processing & presentation—CTSL—meningioma	0.000726	0.00765	CbGpPWpGaD
Boceprevir—CTSK—spinal cord—meningioma	0.000709	0.0425	CbGeAlD
Boceprevir—CTSV—Extracellular matrix organization—CTSL—meningioma	0.000699	0.00737	CbGpPWpGaD
Boceprevir—CTSS—medulla oblongata—meningioma	0.000697	0.0417	CbGeAlD
Boceprevir—CMA1—Extracellular matrix organization—CTSL—meningioma	0.00065	0.00685	CbGpPWpGaD
Boceprevir—CTSS—spinal cord—meningioma	0.000622	0.0372	CbGeAlD
Boceprevir—CTSL—brain—meningioma	0.000606	0.0363	CbGeAlD
Boceprevir—CTSK—Extracellular matrix organization—CTSL—meningioma	0.000579	0.00611	CbGpPWpGaD
Boceprevir—CTSK—cerebellum—meningioma	0.000562	0.0337	CbGeAlD
Boceprevir—CTSV—Adaptive Immune System—AP1B1—meningioma	0.000557	0.00587	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—AP1B1—meningioma	0.000557	0.00587	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—PDGFB—meningioma	0.000499	0.00526	CbGpPWpGaD
Boceprevir—CTSS—Class I MHC mediated antigen processing & presentation—CTSL—meningioma	0.000495	0.00522	CbGpPWpGaD
Boceprevir—CTSS—cerebellum—meningioma	0.000493	0.0295	CbGeAlD
Boceprevir—CTSS—Extracellular matrix organization—CTSL—meningioma	0.000477	0.00503	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—AP1B1—meningioma	0.000462	0.00487	CbGpPWpGaD
Boceprevir—CTSK—brain—meningioma	0.000457	0.0273	CbGeAlD
Boceprevir—CTSS—brain—meningioma	0.0004	0.024	CbGeAlD
Boceprevir—CTSS—Adaptive Immune System—AP1B1—meningioma	0.00038	0.00401	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CD34—meningioma	0.000376	0.00397	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—CD34—meningioma	0.000376	0.00397	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CTSL—meningioma	0.000374	0.00394	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CTSL—meningioma	0.000359	0.00379	CbGpPWpGaD
Boceprevir—CTSV—Immune System—AP1B1—meningioma	0.000338	0.00356	CbGpPWpGaD
Boceprevir—CTSL—Immune System—AP1B1—meningioma	0.000338	0.00356	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—ERBB2—meningioma	0.000334	0.00352	CbGpPWpGaD
Boceprevir—CTSV—Endochondral Ossification—AKT1—meningioma	0.000332	0.0035	CbGpPWpGaD
Boceprevir—CTSV—Extracellular matrix organization—PDGFB—meningioma	0.000325	0.00342	CbGpPWpGaD
Boceprevir—CTSL—Extracellular matrix organization—PDGFB—meningioma	0.000325	0.00342	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CD34—meningioma	0.000312	0.00329	CbGpPWpGaD
Boceprevir—CTSK—RANKL/RANK Signaling Pathway—AKT1—meningioma	0.000311	0.00328	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—CTSL—meningioma	0.00031	0.00327	CbGpPWpGaD
Boceprevir—CTSL—Primary Focal Segmental Glomerulosclerosis FSGS—AKT1—meningioma	0.000302	0.00319	CbGpPWpGaD
Boceprevir—CMA1—Extracellular matrix organization—PDGFB—meningioma	0.000302	0.00318	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—CTSL—meningioma	0.000298	0.00314	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—TSHB—meningioma	0.000296	0.00312	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—PTEN—meningioma	0.000285	0.003	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AP1B1—meningioma	0.00028	0.00295	CbGpPWpGaD
Boceprevir—CTSK—Extracellular matrix organization—PDGFB—meningioma	0.000269	0.00284	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CD34—meningioma	0.000257	0.00271	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CTSL—meningioma	0.000255	0.00269	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CTSL—meningioma	0.000245	0.00258	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AP1B1—meningioma	0.000231	0.00243	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CD34—meningioma	0.000228	0.00241	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CD34—meningioma	0.000228	0.00241	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—PDGFB—meningioma	0.000222	0.00234	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CTSL—meningioma	0.000218	0.0023	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—PLAUR—meningioma	0.000195	0.00206	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CD34—meningioma	0.000189	0.00199	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CTSL—meningioma	0.00018	0.0019	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—PDGFB—meningioma	0.000174	0.00183	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—PDGFB—meningioma	0.000174	0.00183	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—PDGFB—meningioma	0.000167	0.00176	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—PDGFB—meningioma	0.000167	0.00176	CbGpPWpGaD
Boceprevir—CMA1—Signaling by SCF-KIT—AKT1—meningioma	0.000164	0.00173	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD34—meningioma	0.000156	0.00164	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CTSL—meningioma	0.000149	0.00157	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—PDGFB—meningioma	0.000144	0.00152	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—PDGFB—meningioma	0.000138	0.00146	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TSHB—meningioma	0.000128	0.00134	CbGpPWpGaD
Boceprevir—ABCB1—medulla oblongata—meningioma	0.000123	0.00736	CbGeAlD
Boceprevir—CTSS—Innate Immune System—PDGFB—meningioma	0.000119	0.00125	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—ERBB2—meningioma	0.000116	0.00123	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—ERBB2—meningioma	0.000116	0.00123	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—PDGFB—meningioma	0.000114	0.0012	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—ERBB2—meningioma	0.000112	0.00118	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—ERBB2—meningioma	0.000112	0.00118	CbGpPWpGaD
Boceprevir—ABCB1—spinal cord—meningioma	0.00011	0.00656	CbGeAlD
Boceprevir—CMA1—Signaling Pathways—SMO—meningioma	0.000108	0.00114	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PGR—meningioma	0.000104	0.0011	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PDGFB—meningioma	0.000101	0.00107	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PDGFB—meningioma	0.000101	0.00107	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—PTEN—meningioma	9.93e-05	0.00105	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—PTEN—meningioma	9.93e-05	0.00105	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—ERBB2—meningioma	9.65e-05	0.00102	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—PTEN—meningioma	9.53e-05	0.001	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—PTEN—meningioma	9.53e-05	0.001	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—meningioma	9.4e-05	0.000991	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—ERBB2—meningioma	9.26e-05	0.000977	CbGpPWpGaD
Boceprevir—ABCB1—cerebellum—meningioma	8.7e-05	0.0052	CbGeAlD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—meningioma	8.44e-05	0.00089	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PDGFB—meningioma	8.38e-05	0.000884	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—PTEN—meningioma	8.23e-05	0.000867	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—ERBB2—meningioma	7.95e-05	0.000837	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—PTEN—meningioma	7.9e-05	0.000833	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—ERBB2—meningioma	7.63e-05	0.000804	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HES1—meningioma	7.11e-05	0.00075	CbGpPWpGaD
Boceprevir—ABCB1—brain—meningioma	7.06e-05	0.00423	CbGeAlD
Boceprevir—CTSS—Immune System—PDGFB—meningioma	6.9e-05	0.000728	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ERBB2—meningioma	6.78e-05	0.000715	CbGpPWpGaD
Boceprevir—CTSV—Immune System—ERBB2—meningioma	6.78e-05	0.000715	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PTEN—meningioma	6.78e-05	0.000714	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—PTEN—meningioma	6.51e-05	0.000686	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PDGFB—meningioma	6.08e-05	0.000641	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PTEN—meningioma	5.78e-05	0.00061	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PTEN—meningioma	5.78e-05	0.00061	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—AKT1—meningioma	5.72e-05	0.000603	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—AKT1—meningioma	5.72e-05	0.000603	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ERBB2—meningioma	5.62e-05	0.000592	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—AKT1—meningioma	5.49e-05	0.000579	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—AKT1—meningioma	5.49e-05	0.000579	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PTEN—meningioma	4.79e-05	0.000505	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—AKT1—meningioma	4.74e-05	0.0005	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ERBB2—meningioma	4.63e-05	0.000488	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—AKT1—meningioma	4.55e-05	0.00048	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ERBB2—meningioma	4.08e-05	0.00043	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PTEN—meningioma	3.95e-05	0.000416	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—AKT1—meningioma	3.9e-05	0.000412	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALAD—meningioma	3.8e-05	0.0004	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—AKT1—meningioma	3.75e-05	0.000395	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—meningioma	3.65e-05	0.000384	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTEN—meningioma	3.48e-05	0.000366	CbGpPWpGaD
Boceprevir—CTSV—Immune System—AKT1—meningioma	3.33e-05	0.000351	CbGpPWpGaD
Boceprevir—CTSL—Immune System—AKT1—meningioma	3.33e-05	0.000351	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	3.17e-05	0.000334	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALAD—meningioma	2.86e-05	0.000302	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT1—meningioma	2.76e-05	0.000291	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	2.7e-05	0.000285	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TSHB—meningioma	2.45e-05	0.000258	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—meningioma	2.37e-05	0.00025	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT1—meningioma	2.27e-05	0.00024	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT1—meningioma	2e-05	0.000211	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TSHB—meningioma	1.85e-05	0.000195	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	1.85e-05	0.000195	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALAD—meningioma	1.76e-05	0.000186	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	1.56e-05	0.000164	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TSHB—meningioma	1.14e-05	0.00012	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTEN—meningioma	6.66e-06	7.02e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTEN—meningioma	5.03e-06	5.3e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKT1—meningioma	3.84e-06	4.05e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTEN—meningioma	3.1e-06	3.27e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKT1—meningioma	2.9e-06	3.05e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKT1—meningioma	1.79e-06	1.88e-05	CbGpPWpGaD
